Efficacy of rechallenge after first-line immunotherapy for advanced gastric cancer: A retrospective real-world study

• Egile Nagusiak: Mengya Guo (Egilea), Wenhui Zhao (Egilea), Yue Chen (Egilea), Dan Zou (Egilea), Weiwei Peng (Egilea), Huanhuan Sha (Egilea), Guoren Zhou (Egilea), Ying Fang (Egilea), Bo Shen (Egilea)
• Formatua: Liburua
• Argitaratua: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

We aimed to explore the efficacy of rechallenge after first-line immunotherapy in advanced gastric cancer (AGC) and to analyze the factors affecting prognosis based on clinical characteristics. Eighty-five AGC patients who underwent rechallenged after the failure of first-line treatment with immune...